A Randomized, Double-blind, Placebo-Controlled, Dose-Escalation, Phase Ia Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Oral Administration of Alpha-0261 Tablets in Adult Healthy Participants
Latest Information Update: 18 Dec 2025
At a glance
- Drugs Alpha 0261 (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- Sponsors AlphaMol
Most Recent Events
- 18 Dec 2025 New trial record